This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which has an important impact on the information that is given (or not) to patients. Its management requires a close interaction between patients and their many healthcare providers. It is important for patients to develop a full understanding of NAFLD in order to enable them to take an active role in their disease management. This guide summarises the current knowledge relevant to NAFLD and its management. It has been developed by patients, patient representatives, clinicians and scientists and is based on current scientific recommendations, intended to support patients in making informed decisions.
Background: Erectile dysfunction (ED) is a common, consequential, and clinically neglected sexual problem. The current research is designed to study the experience of communication about ED among men with ED, partners of men with ED, and physicians who treat ED. Methods: Qualitative research with 10 men with ED, 10 female partners of men with ED, and 15 physicians who treat men with ED, was used to formulate questions pursued in quantitative research with larger samples of men with ED (N = 449), partners of men with ED (N = 429), and physicians who treat men with ED (N = 389), concerning communication about ED among these parties. Results: Men with ED and partners of men with ED reported strikingly similar perceptions of ED, positive responses to communicating about ED, and negative responses to failing to communicate about ED. Results concerning communication about ED with physicians, preferred attributes of oral therapy for ED, and correlates of PDE5 inhibitor therapy use are reported in Part II of this publication. Conclusions: These findings can be used to guide clinical counselling and patient education to facilitate communication about ED and treatment seeking for this condition where appropriate. ß 2005 WPMH
BackgroundPrimary care has a crucial role to play in the prevention, early detection, referral, and risk factor management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NAFLD/NASH). In 2021, a team of European collaborators developed a continuing medical education (CME) program on NAFLD/NASH that consolidates evidence and clinical best practices tailored to the primary care setting. This article reports on the methodology used to design and develop the CME and the results of a feasibility study.MethodsAn expert advisory group representing both European specialists and general practitioners supported the design of the CME to be implemented in three European settings (Greece, Spain, and Netherlands). The CME features four training modules and problem-based learning using clinical case studies. The CME was tested regarding feasibility and acceptability among a sample of primary care providers (PCPs) in Greece (n = 28) with measurements occurring before, immediately after, and 1 month following the training. Outcome measures included satisfaction with the CME, changes in PCPs’ knowledge, attitudes, confidence, and self-reported clinical practices related to NAFLD/NASH.ResultsThe CME is available as an open-access e-learning course on the European Society for Primary Care Gastroenterology education platform1 in English, Greek, Spanish, and Dutch. The feasibility study documented high levels of satisfaction, with 96% of PCPs reporting they were extremely or very satisfied with the overall training. Statistically significant increases in PCPs’ confidence in NAFLD/NASH-related clinical practices were documented between the pre- and post-assessments. At the follow-up, 62% of GPs reported that the CME had changed their clinical practices related to NAFLD/NASH to a great extent.ConclusionThis CME intervention developed by experts and tailored to PCPs in European settings may serve as an asset for increasing knowledge, confidence, and practice behaviors related to NAFLD/NASH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.